Skip to content
★ Sign in to follow
RP

Robert Plaschke

DNA X, Inc.
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€275k

Latest filing published 23 May 2019 for DNA X, Inc., €275k.

Filing timeline

BuySale
Robert Plaschke

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Robert Plaschke: trading record in brief

This profile gathers the share dealings of Robert Plaschke in DNA X, Inc. In total, 3 filings cover trades dated from 13 May 2019 to 22 May 2019.

Every open-market trade on record is a sale: 1 sale worth €275k. Outside the open market, there are 2 share grants.

On 23 May 2019 came the latest disclosure, an open-market sale for €275k in DNA X, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert Plaschke

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    Chief Executive OfficerExecutivesDNA X, Inc.
    306,900 USD23SEC
    30,000 shares@ US$10.2314.0% of flowCommon StockSEC:0001209191-19-032467:0
  • ◆
    Chief Executive OfficerExecutivesDNA X, Inc.
    0SEC
    383,197 shares0Common StockSEC:0001209191-19-029813:0
  • ◆
    Chief Executive OfficerExecutivesDNA X, Inc.
    2M USD30SEC
    172,439 shares@ US$11.0086.0% of flowCommon StockSEC:0001209191-19-029813:1

3 of 3 declarations